Quick Heal Technologies Ratios

Quick Heal Technologies Ltd Ratios

The Quick Heal Technologies Ltd Ratios page provides a complete fundamental analysis of Quick Heal Technologies Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Quick Heal Technologies Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Quick Heal Technologies Ltd (NSE: QUICKHEAL, BSE: 539678) is currently trading at ₹183.89, with a market capitalization of ₹10.12B. As a major player in the Technology services sector and Packaged software industry, Quick Heal Technologies Ltd remains a key stock for fundamental analysis using Quick Heal Technologies Ltd Ratios.

Quick Heal Technologies Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Quick Heal Technologies Ltd P/E ratio currently stands at 313.70, making it one of the most tracked metrics in Quick Heal Technologies Ltd Ratios.

Historically, the Quick Heal Technologies Ltd P/E ratio has shown strong fluctuations:

• 2024: 313.70
• 2023: 104.96
• 2022: 116.74
• 2021: 12.74
• 2020: 11.21

The rising Quick Heal Technologies Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Quick Heal Technologies Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.51.

Historical P/B trend:

• 2024: 3.51
• 2023: 5.76
• 2022: 1.68
• 2021: 1.64

Quick Heal Technologies Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Quick Heal Technologies Ltd P/S ratio currently stands at 5.66, an important part of Quick Heal Technologies Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 5.66
• 2023: 8.72
• 2022: 2.69
• 2021: 3.10

A stable or declining Quick Heal Technologies Ltd P/S ratio indicates cautious market sentiment.

Quick Heal Technologies Ltd Price to Cash Flow Ratio (P/CF)

The Quick Heal Technologies Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Quick Heal Technologies Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 131.96
• 2022: 22.87
• 2021: 12.72
• 2020: 11.24

The declining Quick Heal Technologies Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Quick Heal Technologies Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Quick Heal Technologies Ltd EV currently stands at ₹13.88B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 13.88B
• 2023: 23.24B
• 2022: 5.59B
• 2021: 7.07B

Quick Heal Technologies Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Quick Heal Technologies Ltd EV/EBITDA ratio is currently 0, a key metric in Quick Heal Technologies Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 117.13
• 2022: 114.09
• 2021: 6.46

Stable Quick Heal Technologies Ltd EV/EBITDA indicates balanced valuation.

Quick Heal Technologies Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Quick Heal Technologies Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Quick Heal Technologies Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Quick Heal Technologies Ltd ROE currently stands at 1.15%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 1.15
• 2023: 5.66
• 2022: 1.22
• 2021: 12.06

Declining ROE indicates pressure on profitability.

Quick Heal Technologies Ltd Ratios Analysis Summary

The Quick Heal Technologies Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Quick Heal Technologies Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Quick Heal Technologies Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.